1. Jain NJ, Kruse LK, Demissie K, Khandelwal M. Impact of mode of delivery on neonatal complications: trends between 1997 and 2005. J Matern Fetal Neonatal Med 2009;22:491–500.
2. Singhi S, Johnston M. Recent advances in perinatal neuroprotection. F1000Res 2019;8(F1000 Faculty Rev): 2031.
3. McNally MA, Soul JS. Pharmacologic prevention and treatment of neonatal brain injury. Clin Perinatol 2019;46:311–25.
6. Kumral A, Tuzun F, Oner MG, Genc S, Duman N, Ozkan H. Erythropoietin in neonatal brain protection: the past, the present and the future. Brain Dev 2011;33:632–43.
12. Natalucci G, Latal B, Koller B, Ruegger C, Sick B, Held L, et al. Effect of early prophylactic high-dose recombinant human erythropoietin in very preterm infants on neurodevelopmental outcome at 2 years: a randomized clinical trial. JAMA 2016;315:2079–85.
17. Kellert BA, McPherson RJ, Juul SE. A comparison of high-dose recombinant erythropoietin treatment regimens in braininjured neonatal rats. Pediatr Res 2007;61:451–5.
18. Gumy-Pause F, Ozsahin H, Mermillod B, Cingria L, Berner M, Wacker P. Stepping up versus standard doses of erythropoietin in preterm infants: a randomized controlled trial. Pediatr Hematol Oncol 2005;22:667–78.
20. Luyt K, Jary SL, Lea CL, Young GJ, Odd DE, Miller HE, et al. Drainage, irrigation and fibrinolytic therapy (DRIFT) for posthaemorrhagic ventricular dilatation: 10-year follow-up of a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2020;105:466–73.
21. Neubauer AP, Voss W, Wachtendorf M, Jungmann T. Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann Neurol 2010;67:657–66.
22. Aher SM, Ohlsson A. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2012;10:CD004865.
24. Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M, et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005;353:782–92.
25. Schmidt B, Davis PG, Asztalos EV, Solimano A, Roberts RS. Association between severe retinopathy of prematurity and nonvisual disabilities at age 5 years. JAMA 2014;311:523–5.
28. Anderson PJ, Doyle LW. Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin Perinatol 2006;30:227–32.